Chao Yao

883 total citations
30 papers, 497 citations indexed

About

Chao Yao is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Chao Yao has authored 30 papers receiving a total of 497 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 9 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Chao Yao's work include Immune Cell Function and Interaction (17 papers), Immune cells in cancer (9 papers) and T-cell and B-cell Immunology (7 papers). Chao Yao is often cited by papers focused on Immune Cell Function and Interaction (17 papers), Immune cells in cancer (9 papers) and T-cell and B-cell Immunology (7 papers). Chao Yao collaborates with scholars based in China, United States and Japan. Chao Yao's co-authors include Chenyuan Gong, Shiguo Zhu, Xiaowen Zhu, Xuewei Yan, Lixin Wang, Lixin Wang, Suyun Li, Zihang Xu, Fang Cheng and Nan Shen and has published in prestigious journals such as Journal of Clinical Investigation, Applied Physics Letters and The Journal of Immunology.

In The Last Decade

Chao Yao

27 papers receiving 495 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Chao Yao China 14 281 218 141 64 47 30 497
Xiaoling Yu China 13 184 0.7× 214 1.0× 100 0.7× 45 0.7× 35 0.7× 36 507
Emira Bousoik United States 10 94 0.3× 215 1.0× 129 0.9× 62 1.0× 38 0.8× 11 434
Sam Tilborghs Belgium 5 115 0.4× 262 1.2× 179 1.3× 124 1.9× 63 1.3× 14 530
Ali Memarian Iran 16 370 1.3× 198 0.9× 140 1.0× 52 0.8× 54 1.1× 37 648
Yaxiong Deng China 7 469 1.7× 160 0.7× 100 0.7× 47 0.7× 40 0.9× 12 649
Yihe Yan China 14 237 0.8× 167 0.8× 138 1.0× 103 1.6× 38 0.8× 37 541
Xiaoming Zhong China 10 171 0.6× 142 0.7× 163 1.2× 106 1.7× 19 0.4× 20 441
Aleksandra Mielczarek‐Palacz Poland 16 458 1.6× 161 0.7× 94 0.7× 62 1.0× 25 0.5× 54 803

Countries citing papers authored by Chao Yao

Since Specialization
Citations

This map shows the geographic impact of Chao Yao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chao Yao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chao Yao more than expected).

Fields of papers citing papers by Chao Yao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chao Yao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chao Yao. The network helps show where Chao Yao may publish in the future.

Co-authorship network of co-authors of Chao Yao

This figure shows the co-authorship network connecting the top 25 collaborators of Chao Yao. A scholar is included among the top collaborators of Chao Yao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Chao Yao. Chao Yao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shen, Weiming, Dan Hu, Chenyuan Gong, et al.. (2025). Grain-sized moxibustion activates dendritic cells to enhance the antitumor immunity of cancer vaccines. Chinese Medicine. 20(1). 73–73.
2.
Jiang, Siyuan, Shiyu Zheng, Chao Yao, et al.. (2025). Heterogeneity of γδ T-cell subsets and their clinical correlation in patients with AML. Frontiers in Immunology. 16. 1552235–1552235.
3.
Zhu, Xinyue, Rujun Zhang, Lixin Wang, et al.. (2025). Rubiadin Mediates the Upregulation of Hepatic Hepcidin and Alleviates Iron Overload via BMP6/SMAD1/5/9-Signaling Pathway. International Journal of Molecular Sciences. 26(3). 1385–1385. 1 indexed citations
4.
Gong, Chenyuan, Rujun Zhang, Dan Hu, et al.. (2024). Euphohelioscopin A enhances NK cell antitumor immunity through GSDME-triggered pyroptosis. Journal of Leukocyte Biology. 116(3). 621–631. 3 indexed citations
6.
Chen, Junjie, Chao Yao, Xiaodan Luo, et al.. (2024). Higher TIGIT+ γδ TCM cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML. Frontiers in Immunology. 15. 1321126–1321126. 5 indexed citations
7.
Zhu, Xinyue, Zhongxian Chen, Lixin Wang, et al.. (2024). Rocaglamide regulates iron homeostasis by suppressing hepcidin expression. Free Radical Biology and Medicine. 219. 153–162. 3 indexed citations
8.
Zhao, Wei, Hongjuan Fang, Tao Wang, & Chao Yao. (2024). Identification of mitochondria-related biomarkers in childhood allergic asthma. BMC Medical Genomics. 17(1). 141–141. 1 indexed citations
9.
Gu, Shuangshuang, Jinsong Zhang, Huihua Ding, et al.. (2023). Involvement of Transcriptional Factor Pbx1 in Peripheral B Cell Homeostasis to Constrain Lupus Autoimmunity. Arthritis & Rheumatology. 75(8). 1381–1394. 15 indexed citations
10.
Su, Lin, Fei Zhang, Hong Li, et al.. (2023). The Tian-Men-Dong decoction suppresses the tumour-infiltrating G-MDSCs via IL-1β-mediated signalling in lung cancer. Journal of Ethnopharmacology. 313. 116491–116491. 8 indexed citations
11.
Meng, Yao, Jianyang Ma, Chao Yao, et al.. (2022). The NCF1 variant p.R90H aggravates autoimmunity by facilitating the activation of plasmacytoid dendritic cells. Journal of Clinical Investigation. 132(16). 21 indexed citations
12.
Xu, Zihang, Jun Shen, Lin Su, et al.. (2021). Pain Relief Dependent on IL-17–CD4+ T Cell–β-Endorphin Axis in Rat Model of Brachial Plexus Root Avulsion After Electroacupuncture Therapy. Frontiers in Neuroscience. 14(4). 55–55. 8 indexed citations
13.
Yan, Xuewei, Chao Yao, Fang Cheng, et al.. (2021). Rocaglamide promotes the infiltration and antitumor immunity of NK cells by activating cGAS-STING signaling in non-small cell lung cancer. International Journal of Biological Sciences. 18(2). 585–598. 60 indexed citations
15.
Gong, Chenyuan, Dan Hu, Xiaowen Zhu, et al.. (2021). Tanshinone IIA enhances susceptibility of non-small cell lung cancer cells to NK cell-mediated lysis by up-regulating ULBP1 and DR5. Journal of Leukocyte Biology. 110(2). 315–325. 13 indexed citations
16.
Qiu, Rong, Xiang Yu, Li Wang, et al.. (2020). Inhibition of Glycolysis in Pathogenic TH17 Cells through Targeting a miR-21–Peli1–c-Rel Pathway Prevents Autoimmunity. The Journal of Immunology. 204(12). 3160–3170. 19 indexed citations
17.
Wang, Lixin, Xiaowen Zhu, Chenyuan Gong, et al.. (2019). The Ancient Chinese Decoction Yu-Ping-Feng Suppresses Orthotopic Lewis Lung Cancer Tumor Growth Through Increasing M1 Macrophage Polarization and CD4+ T Cell Cytotoxicity. Frontiers in Pharmacology. 10. 1333–1333. 37 indexed citations
18.
Ni, Lulu, Lixin Wang, Chao Yao, et al.. (2017). The histone deacetylase inhibitor valproic acid inhibits NKG2D expression in natural killer cells through suppression of STAT3 and HDAC3. Scientific Reports. 7(1). 45266–45266. 55 indexed citations
19.
Luo, Yingbin, Jianchun Wu, Xiaowen Zhu, et al.. (2016). NK Cell-Dependent Growth Inhibition of Lewis Lung Cancer by Yu-Ping-Feng, an Ancient Chinese Herbal Formula. Mediators of Inflammation. 2016. 1–7. 23 indexed citations
20.
Gong, Chenyuan, Chao Yao, Xiaowen Zhu, et al.. (2015). A High-Throughput Assay for Screening of Natural Products that Enhanced Tumoricidal Activity of NK Cells. Biological Procedures Online. 17(1). 12–12. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026